Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation

(2014) K Malottki et al.   HEALTH TECHNOLOGY ASSESSMENT

Genetic and epigenetic predictors of responsiveness to treatment in RA

(2014) Darren Plant et al.   Nature Reviews Rheumatology

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

(2013) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Lack of Association of Variants Previously Associated with Anti-TNF Medication Response in Rheumatoid Arthritis Patients: Results from a Homogeneous Greek Population

(2013) Maria I. Zervou et al.   PLoS One

Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis

(2013) Jing Cui et al.   PLoS Genetics

Treg Cells in Rheumatoid Arthritis: An Update

(2013) Faye A. H. Cooles et al.   Current Rheumatology Reports

Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis

(2012) John D Isaacs et al.   ANNALS OF THE RHEUMATIC DISEASES

Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis

(2012) Maša Umiċeviċ Mirkov et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of Rheumatoid Arthritis Risk Alleles with Response to Anti-TNF Biologics: Results from the CORRONA Registry and Meta-analysis

(2012) Dimitrios A. Pappas et al.   INFLAMMATION

Chromatin marks identify critical cell types for fine mapping complex trait variants

(2012) Gosia Trynka et al.   NATURE GENETICS

Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis

(2012) Sophine B. Krintel et al.   Pharmacogenetics and Genomics

Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response

(2011) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

(2011) K. Chatzidionysiou et al.   ANNALS OF THE RHEUMATIC DISEASES

Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort

(2011) Darren Plant et al.   ARTHRITIS AND RHEUMATISM

Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment

(2010) R. J. L. Tan et al.   ANNALS OF THE RHEUMATIC DISEASES

Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients

(2010) L. R. Coulthard et al.   ANNALS OF THE RHEUMATIC DISEASES

Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF B signalling pathways

(2010) C. Potter et al.   ANNALS OF THE RHEUMATIC DISEASES

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

(2010) C. Salliot et al.   ANNALS OF THE RHEUMATIC DISEASES

Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression

(2010) N. Agmon-Levin et al.   ANNALS OF THE RHEUMATIC DISEASES

Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci

(2010) Darren Plant et al.   ARTHRITIS AND RHEUMATISM

The Sp1 transcription factor binds to the G-allele of the –1087 IL-10 gene polymorphism and enhances transcriptional activation

(2008) L Larsson et al.   GENES AND IMMUNITY